Answer
Zeposia (ozanimod hydrochloride) is indicated for adults with relapsing remitting multiple sclerosis with active disease defined by clinical or imaging features.
Sources for this answer
- Zeposia 0.23 mg, 0.46 and 0.92 mg hard capsulesBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.1 Therapeutic Indications · Version 10Document updated
Sources checked